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The Molecular Characterization
of the Fetal Stem Cell Marker AA4
mice results in the long-term repopulation of T and B
lymphoid compartments with a complete restoration of
immune functions (Potocnik et al., 1997). Collectively,
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these findings indicate that AA4.1 defines early popula-*Department of Molecular Biology
tions of multipotential hematopoietic precursors thatPrinceton University
can give rise to the entire spectrum of mature cells ofPrinceton, New Jersey 08544
the blood system.² Institut D'Embryologie Cellulaire et Moleculaire
In the present study, we have used a retroviral-medi-94736 Nogent Sur Marne
ated expression cloning strategy to identify and charac-France
terize the antigen recognized by the AA4.1 mAb. Our
results demonstrate that the AA4.1 antigen (hereafter
referred to as AA4) is a type I glycosylated transmem-Summary
brane protein with a domain structure that suggests a
role in cell adhesion. Analyses of developing mouseWe have identified and characterized the stem cell
embryos showed that AA4 is present on vascular endo-antigen AA4. This molecule is a type I transmembrane
thelial cells, particularly during the remodeling of theprotein whose overall structure suggests a role in cell
vascular tree. We suggest that AA4 is a novel memberadhesion. During fetal ontogeny (days 9±14 of develop-
of a group of collectively acting adhesion molecules thatment), AA4 is expressed in three major cell types: vas-
play roles during the development of both the hemato-cular endothelial cells, aorta-associated hematopoi-
poietic and cardiovascular systems.etic clusters, and primitive fetal liver hematopoietic
progenitors. In the adult, AA4 is abundant in lung,
Resultsheart, and whole bone marrow. In the adult hemato-
poietic compartment, aa4 transcripts are present in
Expression Cloning of AA4bone marrow CD342/loLin2Sca-11c-Kit1 and CD34hi
As a first step to identifying the antigen recognized byLin2Sca-11c-Kit1 stem and progenitor cell subsets.
AA4.1 mAb, we screened a panel of various cell linesOur observations suggest that AA4 plays a role in cell±
(Table 1) and primary hematopoietic cells for high-levelcell interactions during hematopoietic and vascular
binding to the antibody. The murine B lymphoid cell linedevelopment.
D2N was found to express high levels of the AA4 antigen.
Immunoprecipitation of protein extracts prepared from
D2N cells showed that AA4.1 mAb recognizes a proteinIntroduction
with an apparent molecular weight (Mr) of 130 kDa that
was also present in extracts prepared from the BA number of years ago we showed that the monoclonal
lymphoid cell line M2.4 and AA4-enriched hematopoieticantibody (mAb) AA4.1, originally identified as a B cell
cells derived from the fetal liver and adult bone marrowlineage marker (McKearn et al., 1985), recognizes the
(Figure 1A).entire spectrum of primitive hematopoietic stem and
To identify and characterize the AA4 antigen, a cDNAprogenitor cells in midgestation murine fetal liver (Jor-
library was prepared from D2N cells and cloned into thedan et al., 1990, 1995). It has also been demonstrated
retroviral expression vector REBNA. The cDNA library
that the AA4.1 mAb reacts with multipotent hematopoi-
contained approximately 2 3 105 independent clones.
etic precursors present in the extraembryonic yolk sac
NIH 3T3 cells were infected with the recombinant cDNA
at day 9 or later in gestation (Huang and Auerbach, 1993; library and selected for AA4 expression by flow cytome-
Ray et al., 1996; Yoder et al., 1997). Antibody binding try using the AA4.1 mAb. After two rounds of sorting,
cells are also present in intraembryonic sites where the genomic DNA extracted from AA4-positive cells was
first definitive hematopoietic stem cells originate, the analyzed by PCR amplification using viral vector prim-
paraaortic splanchnopleura (P-Sp) and the aorta/gonad/ ers. A 3.1 kb cDNA amplified from the sorted cells was
mesonephros (AGM) region (Godin et al., 1995; Marcos subcloned for sequence analysis and functional studies.
et al., 1997). In adult mice the AA4.1 mAb defines the Infection of NIH 3T3 fibroblast or EML C1 hematopoietic
most primitive bone marrow pro-B cell compartment as cells with the recombinant retrovirus containing the
well as multipotential stem cells recovering from 5-fluor- cloned cDNA resulted in a population of cells recognized
uracil treatment (Szilvassy and Cory, 1993; Li et al., by the AA4.1 mAb (Figure 1B). In these cells, the antibody
1996). Recent studies demonstrate that expression of recognizes a 130 kDa surface protein that comigrates
the AA4.1 antigen parallels early stages of hematopoi- with the endogenous AA4 from D2N cells (Figure 1C),
etic development during the in vitro differentiation of thus indicating that the cloned cDNA encodes AA4.
embryonic stem (ES) cells (Kabrun et al., 1997; Ling and
Neben, 1997). Moreover, transfer of an AA41CD45R2 Sequence Analysis of AA4
subset of differentiating ES cells into lymphoid-deficient Sequence analysis of the cloned aa4 cDNA revealed a
single open reading frame encoding a type I transmem-
brane protein of 644 amino acids (Figure 2A). The pre-³ To whom correspondence should be addressed (e-mail: ilemi
schka@molbio.princeton.edu). dicted amino acid sequence of AA4 encodes a putative
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Table 1. Expression of AA4 in Transformed Cell Lines
Cell Line ATCC Number Lineage Derivation Expression of AA4
R1.1 TIB-42 T lymphoid 2
BW5147.3 TIB-47 T lymphoid 2
D2N TIB-58 B lymphoid 111
M2.4 2 B lymphoid 1
Ba/F3 2 B lymphoid 2
J558 TIB-6 B lymphoid 2
EML C1 2 erythroid/myeloid/ 1/2
B-lymphoid progenitors
WEHI-3 TIB-68 myeloid 1
M1 TIB-192 myeloid 1/2
P815 TIB-64 myeloid 2
Pluses indicate relative levels of expression as detected by flow cytometry.
leader peptide and a mature protein that contains a long Expression Patterns of AA4
Northern blot analysis showed that AA4 is expressed inextracellular region, a single hydrophobic transmem-
adult lung, heart, and bone marrow and at lower levelsbrane region, and 47 amino acids in the C-terminal cyto-
in ovary, whole embryo (days 10±12), and fetal liver (dayplasmic domain with no obvious signal transduction mo-
14). No detectable expression was found in brain, adulttifs. The extracellular part of AA4 contains two major
liver, or thymus (Figure 3B). In normal tissues and trans-structural moieties, a calcium-dependent carbohydrate-
formed cell lines, a major 7 kb RNA species hybridizedrecognition domain, also known as a C-type lectin do-
with the cloned cDNA (Figures 3A and 3B). In additionmain (Weis et al., 1998), and a cysteine-rich domain
to the 7 kb species, poly(A)-RNA from D2N cells containscomposed of a tandem array of five epidermal growth
a minor band corresponding to a 3.2 kb mRNA (Figurefactor (EGF)-like repeats. Three of these repeats are
3A, lane 8). A comparison with expressed sequencemost homologous with calcium-binding EGF motifs,
tags (ESTs) databases showed that there exist at leastwhich are found in a large number of membrane-bound
eight different sequences corresponding to the 39 un-proteins that require calcium for protein±protein interac-
translated region of the aa4 cDNA. These were derivedtions (Bork et al., 1996). Although the predicted Mr of
from the following mouse tissues: colon (GenBank ac-AA4 is 67 kDa, immunoprecipitation analyses revealed
cession number AA929174), heart (AA435107), lymphtwo major protein products of 130 and 105 kDa, both
node (AA185911 and AA267407), lung (AA220480), mam-of which are recognized by the AA4.1 mAb (Figure 1D).
mary gland (AI021507), spleen (AA145088), and uterusThis large shift in apparent molecular weight most likely
(AI152724). Sequence identity with the ESTs ends imme-results from the addition of O-linked carbohydrate
diately upstream of position 2481 in the 39 untranslatedchains to the AA4 molecule. The overall amino acid se-
region of the aa4 cDNA, indicating that the cloned cDNAquence of AA4 contains two potential N-linked and at
corresponds to an alternatively spliced 3.2 kb aa4least thirteen potential O-linked glycosylation sites within
mRNA. To confirm these results, we isolated a genomicits extracellular domain. Pulse-chase experiments show
clone containing the aa4 gene. The extracellular andthat a 105 kDa precursor form, which appears immedi-
transmembrane domains of AA4 are encoded by a singleately after the pulse labeling, is gradually processed to
exon. The gene contains one intron at amino acid posi-the mature form of 125 kDa in fibroblasts and 130 kDa
tion Ser-634 in the cytoplasmic region of the protein andin hematopoietic cells (Figure 1D). Consistent with this
at least one additional intron within the 39 untranslatedresult, immunoprecipitation of surface biotinylated cells
region (data not shown; A. Tenner, personal communi-using AA4.1 mAb detects a 125±130 kDa surface mole-
cation).cule (Figure 1C).
Database comparisons revealed that AA4 exhibits
high homology to human C1qRP, a putative component Expression of AA4 in Hematopoietic Progenitor Cells
of a receptor complex for complement component C1q, We analyzed the expression of aa4 mRNA in hematopoi-
which is expressed in cells of the myelomonocytic lin- etic cell populations enriched in primitive stem and pro-
eage and in endothelial cells (Nepomuceno et al., 1997; genitor cell activities. In the fetal liver, aa4 was amplified
Nepomuceno and Tenner, 1998). Comparative analysis from AA4-positive cells, whereas in AA4-negative cells
showed that AA4 and C1qRP possess similar domain it was only present at low levels (Figure 3C). In addition,
structures and have approximately 68% amino acid expression levels were high in the AA41Lin2/loSca-11
identity. The highest degree of homology was found c-Kit1 subpopulation previously shown to be enriched
within the EGF-repeat and the cytoplasmic domains of for HSC activity (Jordan et al., 1995). In adult bone mar-
the two proteins (Figure 2B), suggesting an important row, aa4 was detected in lineage marker±positive cells
functional role for these regions. The gene encoding and in CD341Lin2Sca-11c-Kit1 multipotential hemato-
C1qRP is present as a single copy in the human genome poietic progenitors. aa4 transcripts were present at
(Nepomuceno et al., 1997). These findings suggest that lower levels in the CD342/loLin2Sca-11c-Kit1 fraction
(Figure 3C). In all cell populations tested, aa4 expressionC1qRP is a likely homolog of AA4.
Characterization of the Stem Cell Marker AA4
693
cells, expression is readily detectable in the blast cells
and in both hematopoietic and endothelial differentiated
progeny cells (Figure 3D). The hematopoietic expression
is consistent with previous in vitro ES cell differentiation
studies (Kabrun et al., 1997; Ling and Neben, 1997).
Expression of AA4 during Embryonic Development
In situ hybridization showed that aa4 expression is first
detectable in day 9 embryos. Transcripts were found
in the endocardium and vascular endothelium in the
anterior parts of embryos (Figures 4A and 4B). The ex-
pression in endothelial cells, initially restricted to aorta,
omphalomesenteric, and umbilical arteries, later ex-
tends to subcardinal veins, intersomitic arteries, and
perineural vessels (Figure 4C). On day 10, aa4 expres-
sion is detectable over the entire length of the embryo.
No aa4 mRNA or protein could be detected at early
stages of development (days 7±8.5 embryos) in the yolk
sac mesoderm, blood islands, or endothelial cells of the
yolk sac vessels (data not shown). At later stages, aa4
expression in the yolk sac was only found in ompha-
lomesenteric and umbilical arteries, both of which are
of intraembryonic origin (see Figure 4D).
The AA4 protein staining patterns were consistent
with those of mRNA expression. By day 10 of develop-
ment, the endothelial lining of blood vessels uniformly
expressed AA4 except in the ventral parts of the truncal
aorta and omphalomesenteric artery (Figure 5A). The
expression pattern changed after 13 days postcoitum
(dpc), when AA4 levels generally decreased and became
confined to the developing capillary network invading
various organ rudiments such as eye retina and lung
Figure 1. Identification of the AA4 Antigen (data not shown). In sites of early hematopoietic activity,
(A) Immunoprecipitation analysis of AA4 expression using AA4.1 immunopositive cells were detected at 10.5 dpc. The
mAb or rat IgG2b isotype control antibody (IgG). Protein extracts
ventral walls of the aorta, omphalomesenteric, and um-were prepared from D2N cells, M2.4 cells, AA4-depleted fetal liver
bilical arteries contained clusters of hematopoietic cellscells (FLAA42), AA4-enriched fetal liver cells (FLAA41), AA4-
showing weak but consistent AA4 staining (Figure 5B). Itdepleted bone marrow cells (BMAA42), and AA4-enriched bone mar-
row cells (BMAA41). Indicated on the right are positions of molecular is interesting to note that the ventral walls of the arteries
weight markers. harboring hematopoietic clusters also displayed lower
(B) Flow cytometric analysis of NIH 3T3 and EML C1 cells stained staining compared to their dorsal portions (Figures 5A
with PE-conjugated AA4.1 antibody before and after infection with and 5C). At 11 dpc, large groups of rounded, strongly
REBNA/AA4. Incubation with isotype control antibody demon-
immunopositive cells were found in the region underly-strated no detectable staining.
ing the aortic floor (Figure 5D). These cells differ morpho-(C) AA4 expression in retrovirus-infected cells. Biotin-labeled sur-
logically from endothelial cells of blood vessels; they doface proteins were immunoprecipitated using rat IgG2b isotype con-
trol antibody (lanes 1, 3, and 5) or AA4.1 mAb (lanes 2, 4, and 6). not coalesce into the capillary-like tubular structures
Cellular extracts were prepared from D2N (lanes 1 and 2), AA4 NIH with a central lumen nor are they associated with blood
3T3 (lanes 3 and 4), and AA4 EML C1 cells (lanes 5 and 6). cells. A minor proportion of the subaortic AA4-positive
(D) AA4 NIH 3T3 (lanes 2±4) and AA4 EML C1 cells (lanes 6±8) were cells express a common hematopoietic marker CD45
labeled with 35S-methionine and chased with nonradioactive media
(I. G., unpublished data). It is unclear at present whetherfor 10 min (lanes 3 and 7) or 20 min (lanes 4 and 8). Protein extracts
these cells represent distinct differentiation steps ofwere immunoprecipitated using AA4.1 mAb. GFP NIH 3T3 (lane 1)
emerging hematopoietic cells or a stromal cell type in-and GFP EML C1 cells (lane 5) are shown as controls.
volved in hematopoietic development. Further charac-
terization of these cells is currently underway.
correlated with the expression of stem cell markers Circulating AA4-positive cells were observed in large
CD34 and CD43 (Moore et al., 1994; Osawa et al., 1996). vessels only after the colonization of fetal liver. In the
Embryonic stem cells have been shown to generate fetal liver, AA4 staining was detected between days 11
hematopoietic progenitors during in vitro differentiation and 14 of development, corresponding to the period
(Keller, 1995). At early times during in vitro differentia- during which this organ is hematopoietically active. In
tion, ES cells give rise to blast cell colonies, which can day 11 fetal liver, AA4 staining has a predominantly en-
differentiate into both hematopoietic and endothelial lin- dothelial character (Figure 5E). At this stage, the fetal
eages and therefore have been suggested to represent liver contains a large total number of hematopoietic
the immediate progeny of hemangioblasts (Choi et al., cells, but AA4-positive cells are rare. Their numbers in-
crease at 11.5 dpc when AA4-positive cells are found1998). While aa4 is not expressed in undifferentiated ES
Immunity
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Figure 2. Nucleotide Sequence and the Deduced Amino Acid Sequence of AA4
(A) Amino acid sequence is numbered 1 with initiator methionine. Underlined is the putative signal peptide in AA4. The transmembrane domain
is double underlined. Wave line indicates C-type lectin carbohydrate recognition domain. Dotted lines show EGF-like repeats. Dashed lines
indicate calcium-binding EGF motifs.
(B) Comparison of the primary structures of AA4 and human C1qRP.
scattered throughout the whole fetal liver tissue. Con- sequence of AA4 deduced from the cloned cDNA pre-
currently with the increase in the number of AA4-positive dicts a type I glycosylated transmembrane protein
hematopoietic cells, AA4 expression in fetal liver endo- whose domain structure includes an amino-terminal
thelial cells is downregulated (Figure 5F). At 13 dpc, aa4 C-type lectin domain, a tandem array of five EGF-like
expression was first detected in the bone rudiments repeats, a single hydrophobic transmembrane region,
(data not shown). These may be cells of stromal origin, and a short cytoplasmic domain that contains no obvi-
since AA4-positive hematopoietic cells could seldom be ous peptide motifs, which can be found in different
found in the developing bone marrow at this stage. classes of signal transduction molecules. Similar do-
main structures are found in several groups of extracel-
lular proteins with divergent functions, including throm-Discussion
bomodulin and the selectin family of cell adhesion
receptors (Bork et al., 1996; Weis et al., 1998). TheWe describe the identification and molecular character-
ization of the stem cell marker AA4. The amino acid amino-terminal part of AA4 bears a distant homology to
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a rigid configuration to the AA4 molecule, thus facilitat-
ing its optimal presentation for ligand binding. In addi-
tion, the carbohydrate-rich regions tend to interact with
each other, resulting in possible protein dimerization
and aggregation into larger clusters (Weisel et al., 1996).
Database analyses revealed that AA4 is homologous
to a human protein called C1qRP (Nepomuceno et
al., 1997). C1qRP-specific monoclonal antibodies were
shown to inhibit complement component C1q-depen-
dent phagocytosis in monocytes (Guan et al., 1994).
Consequently, it was suggested that C1qRP is a cellular
receptor for C1q that plays a role in C1q-mediated
phagocytic removal of immune complexes and patho-
gens (Nepomuceno et al., 1997). However, no direct
binding of C1qRP to C1q has yet been demonstrated.
In human monocytes, CD43 was identified as the major
component in the C1q-binding protein complex that in-
cludes C1qRP (Guan et al., 1991). Thus, C1qRP may be
an element of a larger receptor complex that binds C1q.
Recently, several other C1q-binding proteins have been
characterized, including complement receptor type 1
(CR1, CD35), which specifically binds to complement
components C1q, C3b, and C4b (Klickstein et al., 1997).
Therefore, at present it is not clear if C1qRP is a genuine
Figure 3. Expression of aa4 in Mouse Tissues and Cells receptor for C1q or if it has a more general role in phago-
cytosis. The high degree of sequence conservation(A) Northern blot hybridization of RNAs from transformed cell lines.
Indicated on the left are positions of 9.44±0.24 kb RNA molecular found within the two proteins suggests that C1qRP is
weight markers. Hybridization with D2N poly(A)1 RNA is shown after a homolog of AA4 and may be involved in some aspects
overnight and 2 hr exposures. Hybridization with GAPDH is shown of hematopoietic and vascular development in humans.
as a control for equal loading.
Based on the structural properties of the AA4 mole-(B) Northern blot hybridization of RNAs from normal mouse tissues.
cule, we hypothesize that it may play a role in the homing(C) RT±PCR analysis of fetal liver- and bone marrow±derived hema-
of hematopoietic progenitors during the colonization oftopoietic cells. Fetal liver cells: AA42 (lanes 1 and 2), AA41 (lane 3),
AA41Lin2/loSca-11c-Kit1 (lane 4), and AA41Lin2/loSca-12c-Kit1 (lane fetal liver. Expression analyses showed that AA4 pat-
5). Bone marrow cells: CD342Lin2Sca-11c-Kit1 (lane 6), CD341Lin2 terns are complex and that the protein may play addi-
Sca-11c-Kit1 (lane 7), and Lin1 (lane 8). Hybridization probes are tional roles, particularly during early stages of vascular
indicated on the right.
development. During fetal ontogeny the vascular system(D) RT±PCR analysis of differentiating ES cells. ES0, undifferentiated
develops by two distinct mechanisms: tissues undergo-cells; BLAST 1 and 2, blast cell colonies; ENDO 1 and 2, differenti-
ing vasculogenesis possess their own endothelial pre-ated endothelial cells; HEMATO 1 and 2, differentiated hematopoi-
etic cells. cursors, whereas tissues vascularized through angio-
genesis depend on invasion by extrinsic precursors
(Pardanaud et al., 1989). A primary vascular plexus thus
becomes established from in situ differentiating angi-a consensus link domain, which is a hyaluronan (HA)-
oblasts, while further blood vessels are generated frombinding region found in proteins involved in the assem-
migrating and proliferating endothelial cells by sproutingbly of the extracellular matrix, cell adhesion, and migra-
or nonsprouting angiogenesis (Pardanaud et al., 1987;tion (Kohda et al., 1996). The solution structure of the
Risau, 1997). Our in vivo expression studies suggest thatlink domain reveals its close similarity to the C-type
AA4 is not significantly involved in early vasculogenesis,lectin domain, with the putative HA-binding site located
since no aa4 mRNA or protein was observed in the yolkat a position analogous to the carbohydrate-ligand bind-
sac or intraembryonic sites where the aorta, ompha-ing site in E-selectin (Kohda et al., 1996; Bajorath et al.,
lomesenteric, and umbilical arteries become estab-1998). This observation is particularly interesting given
lished between days 7.5 and 8 of gestation. Expressiona recent finding that a link family member CD44 can
of AA4 was first detected in the endocardium and vascu-mediate leukocyte rolling on the vascular endothelium
lar endothelium of day 9 embryos. AA4 staining generallyby binding to HA (DeGrendele et al., 1997). It has been
correlated with the remodeling of blood vessels, particu-shown that in selectins, the amino-terminal lectin and
larly in the intersomitic branches of the dorsal aorta andEGF domains constitute the ligand recognition unit in
the developing perineural plexus. Concurrently with thewhich the lectin domain plays an essential role in cell
initiation of angiogenic processes, AA4 expression alsoadhesion. Mutations within the EGF-like domain can
appeared in preexisting larger vessels, such as the dor-also inhibit cell adhesion and affect ligand specificity
sal aorta, and by 10 dpc expanded over the entire em-(Kansas, 1996). Interestingly, the numerous potential
bryo. This expression pattern was maintained at laterglycosylation sites found within the extracellular part of
stages of development during the formation of the capil-AA4 are clustered outside the EGF-like domains,
lary network invading various organ rudiments. aa4 tran-exposing them to interactions with other proteins. The
dense arrays of carbohydrate side chains could provide scripts detected by Northern hybridization in whole adult
Immunity
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Figure 4. In Situ Hybridization Analysis of aa4 mRNA Expression in the Developing Mouse Embryos
Abbreviations: Ao, dorsal aorta; H, heart; OA, omphalomesenteric artery; UA, umbilical artery; YS, yolk sac.
(A) A 9 dpc (18 S) embryo after hybridization with a sense (left) or antisense (right) aa4 probe. Transcripts are first detected in the anterior
region, heart, OA (arrow) and UA (arrowhead). The Ao is only stained anteriorly. Scale bar 5 1 mm.
(B) A 9±9.5 dpc (20 S) embryo is shown. Intraembryonically, aa4 expression extends to the truncal aorta and intersomitic arteries (arrow). No
aa4 expression is detected in the YS. Scale bar 5 1 mm.
(C) A 9.5 dpc (20±25 S) embryo is shown. All intraembryonic blood vessels express aa4. The ventral part of the Ao is unlabeled in the truncal
region (arrow). Scale bar 5 1 mm.
(D) A 9.5 dpc embryo is shown. The YS blood vessels do not express aa4, with the exception of the OA and UA. Scale bar 5 100 mm.
mouse tissues most likely reflect expression in their vas- in the aorta/gonad/mesonephros region (Delassus and
Cumano, 1996; Sanchez et al., 1996). The AGM regioncular components. Expression levels were low in most
tissues examined, possibly due to the limitation of angio- of day 10 embryos becomes the exclusive source of
adult-type HSCs that subsequently colonize the fetalgenesis to wound healing during adulthood (Risau,
1997). Taken together, these results suggest a role for liver (Muller et al., 1994; Medvinsky and Dzierzak, 1996).
At the time of fetal liver colonization, cytologically identi-AA4 during angiogenesis, with involvement in endothe-
lial cell migration, adhesion, or the formation of interen- fiable clusters of early hematopoietic cells are present
in the ventral walls of the aorta, omphalomesenteric,dothelial junctions. An additional role for AA4 in vasculo-
genesis cannot at this point be rigorously excluded. This and umbilical arteries (Garcia-Porrero et al., 1995, 1998;
Wood et al., 1997). AA4-positive multipotential progeni-is suggested by our observation that aa4 transcripts are
detectable in the ES cell±derived blast colonies, which tors are first detected in the P-Sp/AGM region beginning
at 9 dpc (Godin et al., 1995; Marcos et al., 1997). In ourcan differentiate into the hematopoietic and endothelial
cell lineages. Because of its expression in both the he- experiments, AA4 staining of hematopoietic cells was
first observed starting at 10.5 dpc. The low frequencymatopoietic and endothelial cells, AA4 joins the growing
list of molecules such as CD34, Flk-1, SCL, and others of these cells, 15±25 precursors per embryo between
days 9 and 10 of gestation (Godin et al., 1995), maythat play important biological roles in these lineages
(Elefanty et al., 1997). explain why we did not observe them at earlier stages.
In the fetal liver, AA4-positive cells were present afterIt has been shown that before the first hematopoietic
organs (liver and thymus) are colonized by early precur- day 11 of development, corresponding to the period
during which this organ becomes hematopoietically ac-sors, the embryo generates hematopoietic cells in the
extraembryonic yolk sac starting at 7.5 dpc (Moore and tive. Based on previous studies, it is reasonable to con-
clude that these were cell populations enriched in stemMetcalf, 1970), paraaortic splanchnopleura at 8.5±9.5 dpc
(Godin et al., 1995; Cumano et al., 1996), and thereafter cell activity. These cells will presumably give rise to the
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Figure 5. Immunochemical Detection of AA4 Protein Expression in the Developing Embryo
Abbreviations: Ao, aorta; FL, fetal liver; LB, limb bud; NT, neural tube; OA, omphalomesenteric artery; S, somites; SV, subcardinal veins; YS,
yolk sac.
(A) An 11 dpc embryo is shown. AA4 staining of the aortic floor bearing hematopoietic clusters is weaker compared to that of other blood
vessels. Scale bar 5 100 mm.
(B) A hematopoietic cluster (arrow) at higher magnification. Scale bar 5 100 mm.
(C) An 11 dpc embryo is shown. Section at the level of the connection between the aorta and omphalomesenteric artery. Arrows indicate
hematopoietic clusters located in the omphalomesenteric artery. Scale bar 5 100 mm.
(D) An 11 dpc embryo is shown. Groups of AA4-positive cells are present in the region underlying the aortic floor. Scale bar 5 2.5 mm.
(E) An 11 dpc embryo is shown. Hepatic endothelial cells express low levels of AA4. Scale bar 5 100 mm.
(F) An 11.5 dpc embryo is shown. Concurrently with the increase in the number of AA41 hematopoietic cells, AA4 expression in hepatic
endothelial cells is downregulated. Scale bar 5 2.5 mm.
AA4-positive tri- and bipotential progenitors present in of fetal liver by hematopoietic precursors has also been
reported (Garcia-Porrero et al., 1998).the fetal liver at later stages (Cumano et al., 1992; Carls-
son et al., 1995; Lacaud et al., 1998). Interestingly, colo- Our results demonstrate that no aa4 mRNA or protein
is expressed at early stages of development (days 7±8.5)nization of fetal liver by AA4-positive progenitors is fol-
lowed by rapid downregulation of AA4 expression by in the yolk sac blood islands or in the endothelial cells
of yolk sac blood vessels. On 9.5 dpc and after, aa4hepatic endothelial cells. Although circumstantial, this
observation provides an additional indication for a po- expression in the yolk sac was found only in ompha-
lomesenteric and umbilical arteries, both of which aretential role of AA4 as a homing receptor for fetal hemato-
poietic progenitors. Similar downregulation of CD34 ex- of intraembryonic origin. Before circulation becomes es-
tablished, the yolk sac does not contain multipotentialpression in endothelial cells following the colonization
Immunity
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Expression Analysesprecursors that contribute to definitive hematopoiesis
For Western blot analyses, the ECL protein biotinylation system(Cumano et al., 1996; Medvinsky and Dzierzak, 1996).
(Amersham) was used as recommended by the manufacturer. ForThe initial population of hematopoietic precursors,
radioactive labeling, 2 3 106 cells were incubated with 200 mCi
which originates in the yolk sac, provides the developing Tran35S Label (ICN) in 2 ml of cysteine and methionine-deficient
embryo with a primitive generation of erythrocytes (Die- medium for 2 hr at 378C. Cells were washed in PBS and lysed in
0.5 ml of buffer containing 20 mM Tris±HCl (pH 7.6), 150 mM NaCl,terlen-Lievre et al., 1997; Dzierzak et al., 1998). Whether
0.5% NP40, 1 mM PMSF, 5 mM benzamidine, 1 mM sodium vana-or not the expression of AA4 is related to the differences
date, 10 mg/ml aprotinin, and 10 mg/ml leupeptin. The lysates wereobserved between primitive and definitive hematopoi-
cleared by centrifugation and 2 mg of soluble antibody were addedetic precursors remains to be established. We suggest,
to the supernatants followed by 25 ml of protein G-Sepharose sus-
however, that AA4-positive progenitors identified in the pension (Sigma). After a 2±4 hr incubation at 48C with rotation,
9±11 dpc yolk sac (Huang and Auerbach, 1993; Lu et protein G-antibody complexes were pelleted and washed in succes-
sive changes of buffers: wash buffer 1 (1 M NaCl, 10 mM Tris±HClal., 1996; Ray et al., 1996; Yoder et al., 1997) are of
[pH 8], 0.1% NP40), wash buffer 2 (0.1 M NaCl, 10 mM Tris±HCl [pHintraembryonic origin.
8], 0.1% NP40), and wash buffer 3 (10 mM Tris±HCl [pH 8], 0.1%
NP40). Samples were eluted by boiling in SDS loading buffer, sepa-
Experimental Procedures rated by 7% SDS-PAGE, dried, and exposed to X-ray film.
For Northern blot hybridization, RNAs prepared using the acid
Cells and Tissue Culture guanidinium thiocyanate-phenol extraction procedure (Chomczyn-
D2N cells were obtained from the American Type Culture Collection ski and Sacchi, 1987) were separated on formaldehyde-agarose
(ATCC number TIB-58) and maintained in RPMI 1640 medium con- gels and blotted onto the Hybond-N nylon membranes (Amersham).
taining 10% fetal calf serum (FCS); NIH 3T3 fibroblasts were main- Hybridization probes were derived from cloned cDNAs using
tained in DMEM supplemented with 10% FCS; EML C1 cells (kindly 32P-dCTP (NEN) and Ready To Go DNA labeling beads (Pharmacia
provided by Dr. S. Tsai, Fred Hutchinson Cancer Research Center) Biotech).
were cultured in IMDM medium supplemented with 20% horse se- For RT±PCR, poly(A)-RNA was converted into cDNA using Super-
rum and 8% BHK/MKL conditioned medium (Tsai et al., 1994). Cell script II Reverse Transcriptase (GIBCO±BRL) and the CapFinder
lines constitutively expressing AA4 were derived by infection with cDNA amplification kit (Clontech). Gene-specific primers for PCR
the recombinant retrovirus REBNA/AA4. The monoclonal antibody amplification included G3PDH Control Amplimer Set (Clontech);
AA4.1 was a gift from Dr. J. P. McKearn (Monsanto). AA4, 59-TTCAGCAAGCCCTGACTC-39 and 59-GCCACCTTCGAAGC
AATC-39; CD34, 59-GAGCGGTACAGGAGAATG-39 and 59-GCCCAC
CCAACCAAATCA-39; CD43, 59-ACCGCGTTCTTCTGTAAC-39 andcDNA Cloning
59-CAGCTAACAGCAGGATCC-39; and GATA-1, 59-CCATGGATTTTThe retroviral expression vector REBNA was derived from the plas-
CCTGGTC-39 and 59-CTGTGTACCTTCAAGAAC-39. The PCR reac-mid LZRSpBMN-Z (a gift from Dr. G. P. Nolan, Stanford University)
tions were performed in a final volume of 50 ml containing 25 pmolby substituting the LacZ gene with a synthetic polylinker composed
of each primer, 5±10 ng of cDNA, and 1.25 U of Klentaq DNA poly-of EcoRI, XhoI, SfiI, and NotI restriction sites. Poly(A) RNA prepared
merase (Clontech). The samples were amplified for 29 cycles at 948Cfrom D2N cells was converted into cDNA using Superscript II Reverse
(1 min), 568C (30 s), and 728C (2 min). Ten microliters of each sampleTranscriptase (GIBCO±BRL) and an oligo(dT) primer containing a
were separated by agarose gel electrophoresis, transferred to Hy-NotI site, 59-TGGTGTCGACGCAGAGTAGCGGCCGCT18-39. The
bond N membranes, and hybridized with the cloned cDNAs as indi-second strand was synthesized using DNA polymerase I in combina-
cated.tion with E. coli RNAse H and E. coli DNA ligase as described (Gubler
and Hoffman, 1983). An adaptor composed of complementary oligo-
nucleotides, 59-GGCCCGGGCCGGCC-39 and 59-TCGAGGCCGCCC
In Situ Hybridization and ImmunohistochemistryGGGCC-39, was ligated to the cDNA. The cDNAs were digested with
Embryos were derived from BALB/c mice (Iffa-Credo). The day onNotI to produce cDNA molecules with NotI and XhoI termini for
which a vaginal plug was observed was considered day 0.5 of preg-directional cloning. Following agarose gel size fractionation, cDNAs
nancy. Embryos were accurately staged by counting somites andlarger than 2.5 kb were ligated into NotI- and XhoI-digested REBNA
fixed in 4% formaldehyde in PBS at 48C overnight. Whole mount inand electroporated into DH12S cells (GIBCO±BRL). Plasmid DNAs
situ hybridization was performed as described (Henrique et al.,were isolated using Qiagen-tip 100 columns (Qiagen) and trans-
1995). Digoxigenin-labeled riboprobes were synthesized from a 2.5fected into Phoenix E packaging cells (a gift from Dr. G. P. Nolan)
kb XhoI±NcoI fragment of the aa4 cDNA subcloned into pBluescriptfor retrovirus production as described below.
SK, which contains the entire coding region.
For immunohistochemistry, fixed embryos were embedded in
Retroviral-Mediated Gene Transfer 7.5% gelatin in PBS, frozen in isopentane cooled to 2808C, and
For DNA transfections, the ecotropic retrovirus packaging cells stored at 2208C. Cryostat sections (5±20 mm) were defrosted for
Phoenix E were plated at a density of 2 3 106 cells per 60 mm dish 30 min and washed in PBS for 10 min at 408C to remove gelatin.
and transfected with 5 mg of plasmid DNA using 20 ml of lipofecta- Endogenous peroxidase activity was blocked by incubation in 0.3%
mine reagent (GIBCO±BRL). REBNA-transfected cells were selected hydrogen peroxide. Samples were incubated with AA4.1 mAb over-
in puromycin (2 mg/ml) and grown to confluence prior to collecting night at 48C, followed by incubation with biotinylated goat anti-rat
virus supernatant. For infections, the culture medium was supple- (DAKO) antibody for 1 hr at room temperature and peroxidase-
mented with polybrene (Sigma) at 5 mg/ml. The appropriate virus conjugated streptavidin-biotin complex for 30 min at 378C. The Tyra-
was added to the cells and incubated overnight. NIH 3T3 cells in- mide Signal Amplification kit was used as recommended by the
fected with the recombinant retroviruses representative of the D2N manufacturer (Dupont). Sections were mounted in Aquatex (Merck)
cDNA library were selected for the production of the AA4 antigen and photographed using Normanski optics.
by flow cytometry using phycoerythrin-conjugated AA4.1 mAb. After
two rounds of cell sorting, genomic DNA isolated from AA41 cells
was subjected to PCR amplification using retroviral vector primers Stem/Progenitor Cell Enrichment
Timed-pregnant C57BL/6J mice and 5- to 7-week-old female mice59-TGCCGGATCCCAGTGTGGTGG-39 and 59-TCTTTTATTTTATCGT
CGACC-39, which flank the cDNA cloning sites. A 3.1 kb cDNA ampli- were purchased from Jackson Laboratory. Lineage marker-specific
antibodies were purchased from Pharmingen. AA4-positive (AA41)fied from the sorted cells was gel purified, cut with NotI and XhoI, and
subcloned into pBluescript SK for sequence analysis. Nucleotide cells were isolated from day 14 fetal liver and from adult bone
marrow by immunopanning on Petri dishes coated with AA4.1 mAbsequences were analyzed using BLAST programs of the National
Center for Biotechnology Information (NCBI) and ExPASy molecular (Jordan et al., 1995). Cells were further fractionated using fluorescein
isothiocyanate (FITC)-conjugated rat monoclonal antibodies to CD3,biology server from the Swiss Institute of Bioinformatics.
Characterization of the Stem Cell Marker AA4
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CD4, CD8, B220, Gr-1, Mac-1, Ter-119, phycoerythrin (PE)-conju- Garcia-Porrero, J.A., Manaia, A., Jimeno, J., Lasky, L.L., Dieterlen-
Lievre, F., and Godin, I.E. (1998). Antigenic profiles of endothelialgated antibody to Sca-1, and biotinylated antibody to c-Kit. The
and hemopoietic lineages in murine intraembryonic hemogeniclatter was developed with streptavidin allophycocyanin (APC).
sites. Dev. Comp. Immunol. 22, 303±319.Three-color fluorescence-activated cell sorting for lineage negative
to low (Lin2/lo)Sca-11c-Kit1 cells was performed on a multilaser Godin, I., Dieterlen-Lievre, F., and Cumano, A. (1995). Emergence
FACS Vantage with CellQuest software (Becton Dickinson Immuno- of multipotent hemopoietic cells in the yolk sac and paraaortic
cytometry Systems). The bone marrow subsets, CD34hiLin2Sca-11 splanchnopleura in mouse embryos, beginning at 8.5 days postco-
c-Kit1 and CD342/loLin2Sca-11c-Kit1, purified essentially as de- itus. Proc. Natl. Acad. Sci. USA 92, 773±777.
scribed (Osawa et al., 1996), were a gift from Dr. J. Visser (New Guan, E.N., Burgess, W.H., Robinson, S.L., Goodman, E.B.,
York Blood Center). The material from ES-derived hemanglioblastic McTigue, K.J., and Tenner, A.J. (1991). Phagocytic cell molecules
colonies and replated hematopoietic or endothelial cell progeny was that bind the collagen-like region of C1q. Involvement in the C1q-
provided by Dr. G. Keller (National Jewish Medical and Research mediated enhancement of phagocytosis. J. Biol. Chem. 266, 20345±
Center) and was generated as described (Kabrun et al., 1997). 20355.
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